FILLA, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 5.376
EU - Europa 2.687
AS - Asia 2.014
AF - Africa 62
SA - Sud America 17
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.163
Nazione #
US - Stati Uniti d'America 5.234
SG - Singapore 1.001
IT - Italia 817
CN - Cina 801
NL - Olanda 425
FI - Finlandia 342
UA - Ucraina 298
DE - Germania 258
IE - Irlanda 213
CA - Canada 133
SE - Svezia 105
GB - Regno Unito 88
IN - India 74
VN - Vietnam 60
CI - Costa d'Avorio 46
ES - Italia 33
FR - Francia 32
IL - Israele 16
JP - Giappone 16
BE - Belgio 15
BR - Brasile 12
IR - Iran 12
TR - Turchia 11
CZ - Repubblica Ceca 9
ZA - Sudafrica 9
AT - Austria 8
PT - Portogallo 7
RO - Romania 7
HK - Hong Kong 6
TH - Thailandia 6
BG - Bulgaria 5
MU - Mauritius 5
CH - Svizzera 4
GR - Grecia 4
MX - Messico 4
PL - Polonia 4
RU - Federazione Russa 4
AU - Australia 3
CU - Cuba 3
EU - Europa 3
TW - Taiwan 3
CL - Cile 2
DZ - Algeria 2
HU - Ungheria 2
KR - Corea 2
LT - Lituania 2
NO - Norvegia 2
PH - Filippine 2
AL - Albania 1
AR - Argentina 1
AZ - Azerbaigian 1
BZ - Belize 1
CO - Colombia 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ID - Indonesia 1
LK - Sri Lanka 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
PE - Perù 1
PK - Pakistan 1
Totale 10.163
Città #
Chandler 999
Singapore 806
Millbury 411
Amsterdam 398
Ashburn 359
Princeton 342
Jacksonville 316
Nanjing 251
Santa Clara 231
Naples 193
Boston 162
Beijing 144
Wilmington 140
Ottawa 112
Nanchang 93
Napoli 86
Des Moines 60
Dong Ket 60
Norwalk 57
Woodbridge 47
Jiaxing 46
Shenyang 46
Hebei 45
Redwood City 40
Seattle 38
Tianjin 35
Nola 34
Falls Church 33
Boardman 25
Kunming 25
Changsha 23
Houston 23
Kronberg 23
San Mateo 23
Milan 22
Dallas 21
Lawrence 21
Rome 21
Washington 18
Augusta 16
Dublin 16
Pune 16
Indiana 15
Toronto 15
Dearborn 14
Shanghai 14
Munich 13
London 12
Leawood 10
Los Angeles 10
Ann Arbor 9
Changchun 9
Helsinki 9
Orange 9
Torre Annunziata 9
Waanrode 9
Brno 8
Madrid 8
Ardabil 7
Cava De' Tirreni 7
Delhi 7
Lanzhou 7
New Delhi 7
New York 7
Pisa 7
Bordeaux 6
Halle 6
Hangzhou 6
Hong Kong 6
Padova 6
Paris 6
Tokyo 6
Ankara 5
Beau Bassin-Rose Hill 5
Bristol 5
Cape Town 5
Davis 5
Guangzhou 5
Lappeenranta 5
Monmouth Junction 5
Redmond 5
San Jose 5
Sofia 5
Verona 5
Vienna 5
Acerra 4
Birmingham 4
Buffalo 4
Fairfield 4
Frankfurt am Main 4
Fremont 4
Mumbai 4
Pescara 4
Saint Louis 4
Salerno 4
Stockholm 4
Telese 4
Xian 4
Atlanta 3
Baden 3
Totale 6.264
Nome #
Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. 198
SISTEMA NERVOSO. Neurologia - Neurochirurgia - Neuroradiologia 143
Screening of ARHSP-TCC patients expands the spectrum of SPG11 mutations and includes a large scale gene deletion. 139
Spinocerebellar ataxia types 1, 2, 3, and 6: disease severity and nonataxia symptoms. 133
Ataxia-myoclonus syndrome due to a novel homozygous ATP13A2 mutation 75
A genome-wide association meta-analysis identifies a novel locus at 17q11.2 associated with sporadic amyotrophic lateral sclerosis. 72
Ataxia with oculomotor apraxia type 1 in southern italy: late onset and variable phenotype. 66
Epoetin alfa increases frataxin production in Friedreich's ataxia without affecting hematocrit. 66
Modifications of resting state networks in spinocerebellar ataxia type 2 64
A novel mutation in SACS gene in a family from southern Italy 64
SPG5 and multiple sclerosis: clinical and genetic overlap? 63
PINK1 homozygous W437X mutation in a patient with apparent dominant transmission of parkinsonism. 61
Dimethyl Fumarate Mediates Nrf2-dependent Mitochondrial Biogenesis in Mice and Humans 60
Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study 60
Pathological laughter as onset symptom in atypical parkinsonisms 58
Behavioral disorder, dementia, ataxia and rigidity in a large family with Tata box-Binding Protein mutation 55
Recombinant human erythropoietin increasesfrataxin protein expression without increasing mRNA expression 55
A randomized controlled pilot trial of lithium in spinocerebellar ataxia type 2. 55
Reduced striatal [123I]FP-CIT binding in SCA2 patients without parkinsonism 54
Electrophysiologic characterization in spinocerebellar ataxia 17 53
Characterization of nigrostriatal dysfunction in spinocerebellar ataxia 17 53
Emotion Recognition and Psychological Comorbidity in Friedreich’s Ataxia 53
Cognitive and functional connectivity alterations in Friedreich's ataxia 53
Dimethyl fumarate dosing in humans increases frataxin expression: A potential therapy for Friedreich’s Ataxia 53
Application of the p9NORM correction method to timed neuropsychological tests in Parkinson's disease and multiple system atrophy. 53
Cerebellum and cognition in Friedreich ataxia: a voxel-based morphometry and volumetric MRI study 53
Ataxia with oculomotor apraxia type 2: a clinical, pathologic, and genetic study 52
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 51
Relative frequencies of CAG expansions in spinocerebellar ataxia and dentatorubropallidoluysian atrophy in 116 Italian families 51
PPAR-gamma Agonist Azelaoyl PAF Increases Frataxin Protein and mRNA Expression. New Implications for the Friedreich's Ataxia Therapy 51
The Effect of Cerebellar Degeneration on Human Sensori-motor Plasticity 51
Long term follow-up to evaluate the efficacy of miglustat treatment in Italian patients with Niemann-Pick disease type C 51
Autosomal dominant hereditary spastic paraplegia: DHPLC-based mutation analysis of SPG4 reveals eleven novel mutations. 50
Very late onset in ataxia oculomotor apraxia type I. 50
Ataxia with oculomotor apraxia type 1 in Southern Italy: late onset and variable phenotype 49
Genome-wide scan linkage analysis for Parkinson's disease: The European Genetic Study of Parkinson's disease. 48
Why do some Friedreich's ataxia patients retain tendon reflexes? A clinical, neurophysiological and molecular study. 48
Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum 47
Accuracy of clinical diagnostic criteria for Friedreich's ataxia. 47
Cerebellar blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 47
Novel mutation of SACS gene in a Spanish family with autosomal recessive spastic ataxia 46
Complex phenotype in an Italian family with a novel mutation in SPG3A. 46
A multilayer perceptron neural network-based approach for the identification of responsiveness to interferon therapy in multiple sclerosis patients 46
A randomized clinical trial of lithium in multiple system atrophy. 46
Long-term effect of epoetin alfa on clinical and biochemical markers in friedreich ataxia 46
Longitudinal study of a cohort of MSA-C patients in South Italy: survival and clinical features 46
Genetic screening for LRRK2 gene G2019S mutation in Parkinson's disease patients from Southern Italy. 45
Normalization of timed neuropsychological tests with the PATA rate and nine-hole pegboard tests 45
Predictors of survival in spinocerebellar ataxia type 2 population from Southern Italy. 45
Influence of GAA expansion size and disease duration on Central Nervous System impairment in Friedreich's Ataxia. Contribution to the understanding of the pathophysiology of the disease 44
DNA damage induced by polyglutamine-expanded proteins. 44
DNA methylation in intron 1 of the frataxin gene is related to GAA repeat length and age of onset in Friedreich's ataxia patients. 44
A double-blind cross-over trial of amantadine hydrochloride in Friedreich's ataxia. 44
Central cholinergic dysfunction in the adult form of Niemann Pick disease type C: a further link with Alzheimer's disease? 44
Comment: CAG repeats in idiopathic Parkinson disease-To screen or not to screen 44
Peripheral markers of autophagy in polyglutamine diseases 44
Adult normative values for the PATA Rate Test 44
Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease. 43
Benign hereditary chorea: clinical and neuroimaging features in an Italian family. 43
A randomized controlled clinical trial of growth hormone in amyotrophic lateral sclerosis: clinical, neuroimaging, and hormonal results. 43
Be aware of Wolfram syndrome when examining ataxic patients 43
Stability of erythropoietin repackaging in polypropylene syringes for clinical use 43
A wearable proprioceptive stabilizer for rehabilitation of limb and gait ataxia in hereditary cerebellar ataxias: a pilot open-labeled study 43
Variable phenotype in a P102L Gerstmann-Straussler-Scheinker Italian family 42
Friedreich's disease. A linkage study in southern andcentral Italy. 42
INTERGENERATIONAL INSTABILITY AND MARKED ANTICIPATION IN SCA-17. 42
Cerebral blood flow in spinocerebellar degenerations: a single photon emission tomography study in 28 patients. 42
A randomized trial of varenicline (Chantix) for the treatment of spinocerebellar ataxia type 3. 42
A new locus for autosomal recessive hereditary spastic paraplegia maps to chromosome 16q24.3. 42
Le atassie ereditarie 42
Functional MRI signal fluctuations highlight altered resting brain activity in Huntington’s disease 42
Autosomal dominant cerebellar ataxia type I: multimodal electrophysiological study and comparison between SCA1 and SCA2 patients 41
Up-regulation of c-Jun N-terminal kinase pathway in Friedreich's ataxia cells. 41
Chronic Pachymeningitis: a case of neurosyphilis with spastic paraparesis. 41
Autonomic nervous system abnormalities in spinocerebellar ataxia type 2: a cardiovascular neurophysiologic study. 41
Friedreich's disease. A linkage study in southern and central Italy. 41
A genetic study of Parkinson's disease. 41
A recurrent de novo mutation in KCNC1 causes progressive myoclonus epilepsy 41
Spinocerebellar ataxia type 2-neuronopathy or neuropathy? 41
‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab 41
Responsiveness of different rating instruments in spinocerebellar ataxia patients 40
Evidence of a genetic marker for early onset in Friedreich's ataxia. 40
Autosomal recessive progressive myoclonus epilepsy with ataxia and mental retardation. 40
Powerhouse failure and oxidative damage in autosomal recessive spastic ataxia of Charlevoix-Saguenay 40
Variants associated with Gaucher disease in multiple system atrophy 40
Age of onset, sex, and cardiomyopathy as predictors of disability and survival in Friedreich's disease: a retrospective study on 119 patients. 39
Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis 39
Aprataxin 39
Clinical and CT-scan study of a case of cerebellar ataxia and progressive hearing loss: Lichtenstein-Knorr disease? 39
Friedreich's Ataxia Presenting as Isolated Spastic Paraparesis 39
Serum transferrin receptor levels in Friedreich's and other degenerative ataxias. 38
A novel NKX2.1 mutation in a family with hypothyroidism and benign hereditary chorea. 38
Course and outcome of a voltage-gated potassium channel antibody negative Morvan's syndrome. 38
Percutaneous stimulation of mechanoreceptors and peripheral neural transmission in normal subjects and patients with hereditary ataxias. 38
Somatosensory Temporal Discrimination Threshold Is Increased in Patients with Cerebellar Atrophy. 38
Long-term disease progression in spinocerebellar ataxia types 1, 2, 3, and 6: a longitudinal cohort study 38
Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. 37
A novel mutation in GCH-1 gene in a case of dopa-responsive dystonia. 37
Mitochondrial DNA haplogroups influence the Friedreich's ataxia phenotype. 36
A pathogenetic classification of hereditary ataxias: is the time ripe? 36
Totale 5.100
Categoria #
all - tutte 52.046
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.046


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020506 0 0 0 0 73 22 21 8 7 113 120 142
2020/2021982 32 60 78 71 76 111 86 43 103 58 180 84
2021/20221.934 50 37 30 34 22 68 32 97 241 158 301 864
2022/20232.398 415 202 52 209 271 242 5 164 310 398 102 28
2023/20241.553 51 209 220 99 64 111 21 299 6 35 325 113
2024/20251.328 496 537 42 59 194 0 0 0 0 0 0 0
Totale 10.655